FINANCIAL NEWS
ASX Winners And Losers Of Today – 23-04-24
The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day
6:35 PM
Australian Broker Call *Extra* Edition – Apr 23, 2024
Extra Edition of the Broker Call Report
3:20 PM
Uranium Week: From Russia Without Love
A global conference kept the uranium spot market quiet last week, but concerns continue to fester as to just when sanctions will be placed on Russian imports
10:37 AM
Weekly Update On LICs & LITs – 23-Apr-2024
Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX
10:30 AM
Dr Boreham’s Crucible: 4D Medical
The New Criterion’s Tim Boreham uncovers the potential of 4D Medical in the USA
10:00 AM
Bell Potter rates A2M as Hold
With three listed Chinese infant milk formulas having recently reported, Bell Potter notes an average revenue growth decline of -20% year-on-year and an average contribution margin contraction of -500 basis points over the first half.
By comparison, says the broker, a2 Milk Co has reported 2% revenue growth and a milder -180 basis point contraction in the same period.
The broker points out infant milk formula imports into China have remained subdued, down -62% year-on-year in March. Bell Potter feels a2 Milk Co has well executed a transition to PRC labelling, and notes the company has sustained revenue in a falling market.
The Hold rating and target price of $5.70 are retained.
Macquarie rates RMS as Neutral
While most 3Q metrics were previously released, management at Ramelius Resources increased FY24 guidance, which was slightly better than Macquarie anticipated.
Guidance increased by 6% to 285-295koz with costs (AISC) between $1,550-1,650oz. The company produced 86.9koz in the 3Q.
The analyst retains a cautious view on Ramelius as the Rebecca pre feasibility (PFS) due in mid-2024 could be weaker than market expectations. Neutral.
The broker's target rises to $2.00 from $1.90 on a valuation roll-forward and an increased FY24 EPS forecast due to the better 3Q performance and higher-than-expected guidance.
Citi rates S32 as Downgrade to Neutral from Buy
South32 stocks experienced a rally yesterday amid news of key aluminium and alumina assets performing. Year-to-date, points out Citi, aluminium production is up 1%, with Hillside achieving record production and Brazil continuing its ramp up toward nameplate capacity.
The broker also notes news of insurance cover for Australian Manganese likely spurring the share price increase, with operations having been on hold since March following cyclone damage.
South32 is working with its insurers to assess expected insurance recoveries, and is confident the impact can be mitigated through insurance payments and higher near-term manganese prices.
The rating is downgraded to Neutral from Buy and the target price increases to $3.80 from $3.50.
Click here to see full report
ANALYSIS & DATA
FNARENA'S MARKET CONSENSUS FORECASTS
To display the stock analysis for a company please enter the company code:
RMS | RAMELIUS RESOURCES LIMITED
Abbreviated format - see the full version here
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$2.06 22 Apr |
0.000 OPEN $2.11 |
0.000 HIGH $2.12 |
6,988,785 LOW $2.02 |
TARGET | |||
$2.210 7.3% upside | |||
Franking for last dividend paid out: 100% |
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | N/A | 17.9 | xxx |
DPS (cps) | xxx | N/A | 3.7 | xxx |
EPS Growth | xxx | N/A | N/A | xxx |
DPS Growth | xxx | N/A | N/A | xxx |
PE Ratio | xxx | N/A | 11.0 | xxx |
Dividend Yield | xxx | N/A | 1.9% | xxx |
Div Pay Ratio(%) | xxx | N/A | 20.5% | xxx |
DAILY FINANCIAL NEWS
Dr Boreham’s Crucible: 4D Medical
The New Criterion’s Tim Boreham uncovers the potential of 4D Medical in the USA
10:00 AM - Small Caps
Companies are expected to ramp up their psychosocial safety strategies following a slew of legislation and legal precedents and ahead of new disclosure standards
Apr 22 2024 - ESG Focus
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
Apr 20 2024 - Australia
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Apr 19 2024 - Australia
Bank of Queensland’s result beat forecasts but brokers claim low quality, and line up to retain Sell ratings
Apr 18 2024 - Australia
A glance through the latest expert views and predictions about commodities: potential upside as gold stocks bridge the gap to a surging gold price; plus rising rare earths price forecasts
Apr 18 2024 - Commodities
PR NEWSWIRE
AUSTRALIAN BATTERY MATERIALS INNOVATOR ANNOUNCES US EXPANSION
10:00 AM - PR NewsWire
TTC Announces Strategic Expansion into Western Australia with New Perth Office
6:00 AM - PR NewsWire
Sustainable Shopping Meets Smart Savings on Feebee AU
Apr 22 2024 - PR NewsWire
AGCO Agriculture Foundation Donates $450,000 AUD to Rural Aid Australia
Apr 22 2024 - PR NewsWire
Impact X Summit 2024 convenes in a bid to bolster Australia’s COP31 bid
Apr 22 2024 - PR NewsWire
Traidmarc’s Masterpiece Album “Slept Broke Woke Up Rich” Resonates with Profound Storytelling and Powerful Themes
Apr 22 2024 - PR NewsWire
RUDI'S VIEWS
Rudi’s View: Shaky Sentiment Ahead Of Corporate Updates
In this week's Weekly Insights: -Shaky Sentiment Ahead Of Corporate Updates-Everybody's A Gold Bull-Best Buys & Conviction Calls By Rudi…
Apr 17 2024
DAILY MARKET REPORTS
ASX Winners And Losers Of Today – 23-04-24
The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day
6:35 PM
Australian Broker Call *Extra* Edition – Apr 23, 2024
Extra Edition of the Broker Call Report
3:20 PM
The Overnight Report: Rebound
With Iran and Israel calling a draw, markets have rebounded sharply. S&P500 up 0.9%. (Available for non-subscribers after 10am)
9:00 AM
ASX Winners And Losers Of Today – 22-04-24
The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day
Apr 22 2024
Australian Broker Call *Extra* Edition – Apr 22, 2024
Extra Edition of the Broker Call Report
Apr 22 2024
The Monday Report – 22 April 2024
Wrap of events affecting the market on Friday night and the weekend and a preview of the week ahead
Apr 22 2024
WEEKLY REPORTS
Uranium Week: From Russia Without Love
A global conference kept the uranium spot market quiet last week, but concerns continue to fester as to just when sanctions will be placed on Russian imports
10:37 AM
Weekly Update On LICs & LITs – 23-Apr-2024
Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX
10:30 AM
Australian Listed Real Estate Tables – 22-04-2024
FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data
Apr 22 2024
Weekly Ratings, Targets, Forecast Changes – 19-04-24
Weekly update on stockbroker recommendation, target price, and earnings forecast changes
Apr 22 2024
In Case You Missed It – BC Extra Upgrades & Downgrades – 19-04-24
A summary of the highlights from Broker Call Extra updates throughout the week past
Apr 19 2024
Weekly Top Ten News Stories – 19 April 2024
Our top ten news stories from 11 April 2024 to 18 April 2024
Apr 19 2024
Next Week At A Glance – 22-26 Apr 2024
A brief look at important company events and economic data releases next week
Apr 19 2024
In Brief: Made In Australia, Insurance & Groceries
Weekly Broker Wrap: beneficiaries of the Future Made in Australia Act; rising excesses for general insurers; plus impacts of grocery market inquiry
Apr 19 2024
The Short Report – 18 Apr 2024
FNArena’s weekly update on short positions in the Australian share market
Apr 18 2024
THE MARKETS
Click item/line to change chart
FNARENA WINDOWS
Window on URANIUM
Uranium Week: From Russia Without Love
A global conference kept the uranium spot market quiet last week, but concerns continue to fester as to just when sanctions will be placed on Russian imports
10:37 AM
Window on WEALTH MANAGEMENT & INVESTMENTS
Weekly Update On LICs & LITs – 23-Apr-2024
Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX
10:30 AM
Window on MEDICAL EQUIPMENT & DEVICES
Dr Boreham’s Crucible: 4D Medical
The New Criterion’s Tim Boreham uncovers the potential of 4D Medical in the USA
10:00 AM
SMSFUNDAMENTALS
SMSFundamentals: Inflation Beats Covid, Markets As Retirement Influencer
Australians have become less comfortable with their plans for retirement, and inflation is to blame
Nov 29 2023